Skip to search formSkip to main contentSkip to account menu

Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase

Known as: Polycythemia Vera, "Spent" Phase, Polycythemia Vera, Post-Polycythemic Myelofibrosis and Myeloid Metaplasia Stage 
Progression of polycythemia vera characterized by decreased erythropoiesis and granulopoiesis, reticulin and collagen fibrosis of the bone marrow… 
National Institutes of Health

Related topics

Related topics

19 relations
Bone MarrowBone marrow stem cellChromosome 13q deletionExtramedullary Hematopoiesis (disorder)

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
A Multicenter, Open-Label, Pilot Study of Alisertib (MLN8237), a Novel Inhibitor of Aurora Kinase a, in Myelofibrosis
Background: Primary/Post-Essential/Post-Polycythemic Myelofibrosis (MF) is characterized by impaired maturation of GATA1… 
Review
2013
Review
2013
A rare der(Y)t(Y;1)(q12;q12) in a patient with post-polycythemic myelofibrosis: a case report.
We describe a case of post-polycythemic myelofibrosis harboring der(Y)t(Y;1)(q12;q12). The patient was a 69-year-old man and was… 
2008
2008
Cyclic severe elevated procalcitonin serum levels in a patient with post polycythemic myelofibrosis carrying a V617F-JAK2 mutation
Dear Editor, Procalcitonin (PCT) is a highly specific serum marker for the differential diagnosis in patients with systemic… 
Highly Cited
2003
Highly Cited
2003
Karyotypic abnormalities in myelofibrosis following polycythemia vera.
Review
1992
Review
1992
Chromosome 11 rearrangement at band 11q21 in a patient with essential thrombocythemia.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)